This work is licensed under a Creative Commons Attribution 4.0 International License.
| DRACP ID | Peptide Name | Sequence | Sequence Length | Origin |
|---|---|---|---|---|
| DRACP00469 | BP16 | KKLFKKILKKL | 11 | Synthetic |
| DRACP00470 | BP81 | LKLFKKILKFL | 11 | Synthetic |
| DRACP00471 | BP105 | LKLFKKILKYL | 11 | Synthetic |
| DRACP00472 | BP307 | RRLFRRILRYL | 11 | Synthetic |
| DRACP00473 | BP325 | CLBKKLFKKILKKL | 14 | Synthetic |
| DRACP00482 | BP327 | CREKAKKLFKKILKKL | 16 | Synthetic |
| DRACP00483 | BP308 | RRLFRRILRRL | 11 | Synthetic |
| DRACP00484 | BP76, Cecropin A (2-8)[W2K] + Melittin (6-9)[V8F] | KKLFKKILKFL | 11 | Synthetic |
| DRACP00713 | BP100 | KKLFKKILKYL | 11 | antimicrobial peptides |
| DRACP00948 | BP329 | CLBCREKAKKLFKKILKKL | 19 | Synthetic |
| DRACP01307 | Sequence 1 from Patent US 20100279918 | CREKA | 5 | Synthetic construct |
| DRACP02529 | CLB | CLB | 3 | Synthetic |
| DRACP02530 | CLB-CREKA | CLBCREKA | 8 | Synthetic |
This work is licensed under a Creative Commons Attribution 4.0 International License.